Terbaru

  • China Eastern Airlines partecipa alla China-Italy Food Culture Research Conference

    Il 17 novembre, esperti e studiosi della Nankai University e dell'Università Santa Anna di Pisa hanno redatto congiuntamente un rapporto di ricerca dal titolo "Il ruolo della ristorazione aerea nella promozione della cultura gastronomica tra Italia e Cina nel contesto dell’Anno del Turismo e della Cultura Italia-Cina del 2022 - Case study su China Eastern Airlines”, pubblicato in cinese e in italiano.
  • FastData Released the First TikTok Ecological Industry Report

    On September 16, the 2022 Global Short Video Summit hosted by FastData came to a successful conclusion. At the summit, many entrepreneurs from the forefront of TikTok's business ecology shared a lot of contents and insights. Meanwhile the TikTok Ecological Sky Eye Award for the first half of FastData was given at the summit.
  • Ultra-high PvTv program, finally released a few Profit quota!

    When talking about the field of quantum technology, most people’s first association is Times Technology Quantum Analysis Team. Among which the most well-known benchmark technology leading the era of quantum hegemony is the “Quantum Computer Quantityindex System”.
  • Konfrontasi dan pencerahan pertemuan G20

    Samit G20 ke-17 akan berlangsung di Bali, Indonesia, dari 15 November ke 16 November 2022. tema Samit adalah "pemulihan umum, pemulihan kuat", yang melibatkan masalah spesifik seperti "infrastruktur kesehatan global", "transformasi digital" dan "transformasi energi". Selain pertemuan, negara-negara telah menjalankan konfrontasi eksplorator disekitar beberapa isu regional dan global, dan Samit Dollar AS Cina juga telah menjadi fokus utama pertemuan G20 ini. Negara tamu harus memperhatikan bagaimana negara-negara kecil dan ukuran pertengahan yang diwakili oleh Indonesia harus mencari jalan penge
  • Komputasi adalah Produktivitas . UtilityNet Mengubah Komputasi dari Teknologi Menjadi Insentif .

    "Komputasi adalah kekuatan produktif pertama dari ekonomi digital . " Pada 29 Juli 2022, di Sub-forum Sains dan Teknologi SenseTime dari Konferensi Komputasi Pertama di Tiongkok, Gao Shanshan, direktur Pusat Penelitian Kerjasama Internasional Media Digital AS Shandong Sino mengatakan, di era AI, infrastruktur komputasi terus berubah seperti industri keuangan, kedokteran, dan pusat data.
  • The Grand Opening of China International Huangjiu Industry Expo 2022 & 28th Shaoxing Huangjiu Festival

    On November 7th , China International Huangjiu Industry Expo 2022 and the 28th Shaoxing Huangjiu Festival were grand opening in Shaoxing Huangjiu town, Zhejiang Province. The Event are organized by China Alcoholic Drinks Association (CADA) and Shaoxing Municipal People’s Government. More than 100 Huangjiu companies and 1000 products participated in the exhibition. Opening Ceremony, China Huangjiu Development Forum, China Huangjiu International Exchange Summit 2022,China Huangjiu New Media (Digital Marketing) Forum were held At the same time.
  • 2022 Hebei Brand Promotion -SIAL Inter Food in Indonesia

    To enhance the publicity and influence of “Hebei Brand", and trade promotion for food enterprises in Hebei Province, “2022 Hebei Brand Promotion—SIAL Inter Food in Indonesia”,hosted by Hebei Provincial Convention & Exhibition Promotion Center (Hebei International Business Information Center) ,organizer by Jiangsu New international Convention & Exhibition (Group) Co., Ltd, has been successfully held in Jakarta International Expo (JIExpo) on 9th November.
  • China Eastern Airlines firma il primo ordine dell'aviazione civile al 5° CIIE: il totale supera l'anno scorso

    Il 5 gennaio, primo giorno del 5° China International Import Expo, China Eastern ha firmato il primo ordine per l'industria dell'aviazione civile di questa edizione, per motori V2500 con Pratt & Whitney, società aerospaziale di fama internazionale con cui ha collaborato per più di 20 anni.

Tautan ramah

Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic

04-10    

On April 4, 2020, Phoenix TV broadcast a report on Yiling Pharmaceutical. It was reported that the global epidemic continued to worsen. At the China-Europe anti-epidemic exchange meeting, the recovery rate of patients treated with Lianhua Qingwen Capsule of Yiling Pharmaceutical co., LTD was as high as 91.5 percent, which has become a hot spot. Since 2004, Lianhua Qingwen Capsule has been listed by the national health commission of China, the state administration of traditional Chinese medicine and other departments in the treatment of influenza and other respiratory diseases for more than 20 times. It has played an important role in the prevention and control of major epidemics. On March 30, Lianhua Qingwen Capsule was approved by the ministry of health of Thailand for the registration of modern herbal medicine, which indicated that Yiling pharmaceutical co., a representative of modern Chinese medicine enterprises in China, had the qualification to sell Lianhua Qingwen Capsule as a drug in the Thai market.

Lianhua Qingwen Capsule helps prevent and control the global epidemic


At the beginning of 2020, COVID - 19 outbreak occurred in Wuhan, China, as the medicine recommended by the national health commission of China in the "diagnosis and treatment scheme of pneumonia infected by novel coronavirus", the market demand of Lianhua Qingwen capsules (granules) produced by Yiling Pharmaceutical co., LTD surged. In order to ensure market supply and help prevent and control the epidemic, all the production lines of Yiling Pharmaceutical co., ltd. are racing against time to produce Lianhua Qingwen products within 24 hours." When the outbreak came, we immediately donated 10 million yuan of Lianhua Qingwen capsules to the Red Cross society of China, of which 5 million yuan of Lianhua Qingwen capsules were transported overnight to the epidemic area in Wuhan to ensure the market demand. At the same time, we also donated products to foreign countries, such as Iraq and Italy. Yiling Pharmaceutical general manager Wu Xiangjun said in an interview.

In the covid-19 prevention and control programs successively released by more than 20 provinces and cities including Hubei, Guangzhou, Zhejiang, Shandong and Hebei, Lianyanghua Qingwen capsules (granules) are recommended. In an interview, Jia zhenhua, director of the Yiling medical research institute, pointed out that "the formula of Lianhua Qingwen is to include the pathogenesis of such diseases as exogenous febrile diseases (respiratory diseases caused by viruses in western medicine) and its treatment drugs."


The good curative effect of Lianhua Qingwen capsule is due to its characteristic of active intervention in multi-target therapy. Hou Yunlong, deputy director of the new drug evaluation center of Yiling medical research institute, told the reporter: "We found that Lianhua Qingwen has certain antiviral replication ability at the cell. When the virus infects the host cell, the host cell will have a certain immune response, and this immune response will release a number of pro-inflammatory factors.”

The overseas business layout of Yiling keeps accelerating

While actively promoting the fight against the "epidemic", Yiling Pharmaceutical's overseas business layout is also accelerating. On March 30, Yiling pharmaceutical announced that it had obtained the approval from the ministry of health of Thailand for the registration of modern herbal medicine, and approved Lianhua Qingwen capsules to comply with the registration of Thailand's modern herbal medicine standards, which brought more international recognition to traditional Chinese medicine.

"Through this outbreak, there has been a significant change in western European and American countries' understanding of traditional Chinese medicine." Zhao Shaohua, deputy general manager of Yiling Pharmaceutical co., said in an interview, "Lianhua Qingwen has been sold in some countries for many years. It used to be mainly used to treat flu, and there was a normal sale every year. Following the global outbreak of covid-19 this year, the demand for Lianhua Qingwen has increased exponentially. This has laid a very good foundation for Lianhua Qingwen 's future sales in the international market.

At present, Yiling Pharmaceutical products such as Tongxinluo capsule, Lianhua Qingwen capsule, Shensong Yangxin capsule, Qiliqiangxin capsule, Yangzheng Xiaoji capsule have been registered and sold in Korea, Vietnam, Russia, Canada, Singapore, Indonesia and other countries. Tongxinluo capsule has also been included in Vietnam's national health insurance directory. Lianhua Qingwen capsule has been registered in Hong Kong and Macao, as well as in Canada, Mozambique, Indonesia, Brazil, Romania, Thailand and other countries, and has carried out phase II clinical study in the United States.

On the internationalization of traditional Chinese medicine, Wu Xiangjun told reporters: "Yiling Pharmaceutical has set up the world federation of traditional Chinese medicine collateral disease branch, as well as in Canada, Europe, northern Europe. The theory of collateral disease has become a window for the world to understand the culture of traditional Chinese medicine, and a bright spot for the culture of traditional Chinese medicine to enter the world. With the deepening of people's understanding of traditional Chinese medicine and its wide spread, I believe traditional Chinese medicine will be a bright name card for China's internationalization in the future."



Penafian: Artikel ini direproduksi dari media lain. Tujuan pencetakan ulang adalah untuk menyampaikan lebih banyak informasi. Ini tidak berarti bahwa situs web ini setuju dengan pandangannya dan bertanggung jawab atas keasliannya, dan tidak memikul tanggung jawab hukum apa pun. Semua sumber daya di situs ini dikumpulkan di Internet. Tujuan berbagi hanya untuk pembelajaran dan referensi semua orang. Jika ada pelanggaran hak cipta atau kekayaan intelektual, silakan tinggalkan pesan kepada kami.
Kembali ke atas
© Hak Cipta 2009-2020 Masyarakat Ekonomi Indonesia      Hubungi kami   SiteMap